Pharmacovigilance And Drug Safety Software Market Size Is Anticipated To Reach USD 17.3 Billion By 2030
San Francisco, 11 May 2023: The Report Pharmacovigilance And Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode (On Premise, On Demand), By End-use, By Region, And Segment Forecasts, 2023 - 2030 The global pharmacovigilance and drug safety software market size is anticipated to reach USD 17.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 10.30% from 2023 to 2030. The key factors driving the market growth include the increasing need to track and manage adverse drug reactions (ADR), comply with regulatory norms, increase adoption by end-users, interoperability, and product upgrades by key companies. In February 2022, Oracle’sArgus (for safety management) and Clinical One (for clinical trial management) were implemented by Clinixir—a Thailand-based CRO. Various end-users such as pharmaceutical, and biotechnology companies, are adopting pharmacovigila